Tag: corruption

Playing favorites? Hospital boards, donors get COVID shots

While millions of Americans wait for the COVID-19 vaccine, hospital board members, their trustees and donors around the country have gotten early access to the scarce drug or offers for vaccinations, raising complaints about favoritism tainting decisions about who gets inoculated and when.

In Rhode Island, Attorney General Peter Neronha opened an inquiry after reports that two hospital systems offered their board members vaccinations. A Seattle-area hospital system was rebuked by Washington Gov. Jay Inslee after it offered COVID-19 vaccination appointments to major donors. And in Kansas, members of a hospital board received vaccinations during the first phase of the state’s rollout, which was intended for people at greater risk for infection.

Hospitals in Florida, New Jersey and Virginia also have faced questions about distributing vaccines, including to donors, trustees and relatives of executives.

The disclosures could threaten public confidence in a national rollout already marked by vaccine shortages, appointment logjams and inconsistent standards state to state for determining who’s eligible.

Keep reading

SEC Issues Vague Threats Against Everyone Involved in the GameStop Stock Saga

The Securities and Exchange Commission broke its silence Friday morning on the populist investor uprising that has sent the stock price of beleaguered retailer GameStop “to the moon,”warning everyone involved that they are watching… and, for the time being, not doing a whole lot else, it seems.

“The Commission will closely review actions taken by regulated entities that may disadvantage investors or otherwise unduly inhibit their ability to trade certain securities,” the joint statement from acting SEC Chair Allison Herren Lee and the three commissioners.

Keep reading

Biden v. Diabetics: New Freeze on Trump’s Lower Cost Insulin and Epinephrine Rule Benefits Big Pharma

Big Pharma did not like Donald Trump, but they certainly like Joe Biden – especially now. 

In an ongoing frenzy to undo everything Trump did over the last four years, Joe Biden froze a December rule aimed at lowering prescription drug prices for insulin and epinephrine. 

On Thursday, Biden’s Department of Health and Human Services announced the new rule would be put on hold, along with several other Trump-era orders pending a 60 day review, The Federalist reports. Biden Chief of Staff Ron Klain directed federal agencies on Wednesday to pause orders that had been signed and published by Trump’s administration but not yet effective. 

In December, 2020 Trump ordered community health centers deliver savings and discounts to low-income patients for the purchase of insulin and epinephrine in efforts to make high drug costs more affordable. Insulin is used to treat diabetes, which more than 20 million Americans struggle with every day, while epinephrine is used to treat allergic reactions.

Big Pharma hated Trump because one of his campaign promises was lowering the prices of important pharmaceutical drugs, which he tackled during his term. Trump’s “most favored nation” law aimed to lower prices in Medicare by linking the costs of certain medicines to cheaper prices in other developed countries. Obviously, Big Pharma strongly opposed the measure, arguing it would limit access.

The big three insulin producers are Eli Lilly and Company, Novo Nordisk A/S, and Sanofi S.A., in which they dominate more than 90% of the world insulin market by value, SWFI reports.

Indeed, these three companies will benefit greatly from the freeze. 

Interestingly enough, during the 2020 election cycle Eli Lilly gave $138,880 to Joe Biden. Perhaps he is just returning the favor.

Biden has faced much scrutiny after the freeze, many wondering what is the point?

Keep reading

US Scientist With Close Ties To Wuhan Lab Discussed Manipulating Bat-Based Coronaviruses Just Weeks Before Outbreak

A U.S. doctor who is part of the World Health Organization team investigating the origins of the COVID-19 pandemic discussed his work manipulating bat-based coronaviruses in labs just weeks before the COVID-19 outbreak in Wuhan.

Dr. Peter Daszak, a close associate with China’s premier bat-based coronavirus researcher and a key figure in directing taxpayer funds to the Wuhan Institute of Virology, explained how easy it was to alter coronaviruses during a podcast interview filmed Dec. 9, 2019.

“You can manipulate them in the lab pretty easily,” Daszak said. “Spike protein drives a lot of what happens with the coronavirus. Zoonotic risk. So you can get the sequence, you can build the protein — and we work with Ralph Baric at [the University of North Carolina] to do this — and insert the backbone of another virus and do some work in the lab.”

It’s unclear where the coronavirus manipulation Daszak described in the podcast, also known as gain of function research, was conducted. Daszak did not return multiple requests for comment.

Keep reading

Right On Cue For Biden, WHO Admits High-Cycle PCR Tests Produce COVID False Positives

Were the ‘conspiracy theorists’ just proven right about the “fake rescue plan” for COVID?

Did the ‘science-deniers’ just get confirmation that it was political after all?

The short answer to both of these questions regarding the COVID-19 ‘casedemic’ and the fallacy of asymptomatic PCR testing is YES and YES!

Keep reading